跳至主要内容
临床试验/ACTRN12619001708145
ACTRN12619001708145招募中2 期

Randomized controlled trial (RCT) comparing between High versus Standard dose caffeine citrate for apnoea in prematurity for premature baby with gestational age 28 to 32 weeks.

Hospital Universiti Sains Malaysia0 个研究点目标入组 78 人开始时间: 2019年12月4日最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
78

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment

入排标准

年龄范围
1 Hours 至 34 Weeks(—)
性别
All

入选标准

  • 1.Prematurity 26 to 32 completed weeks admitted to Neonatal Intensive Care Unit Hospital
  • Universiti Sains Malaysia
  • 2.24 hours periextubation period if ventilated

排除标准

  • 1.Hydrops fetalis
  • 2.Major congenital anomaly (Major malformations causing significant functional or
  • cosmetic impairment or being life-limiting. ‘Examples of major malformations include
  • neural tube defect, hypoplastic left heart, ventral wall defect, and craniofacial cleft’)
  • 3.Major neurological condition; examples Grade 3 or 4 intraventricular haemorrhage
  • 4.Contraindication on starting oral medication (Examples Necrotising Enterocolitis,
  • bowel pathology like malrotation, Hirschprung disease)
  • Withdrawal criteria
  • 1.Premature baby who developed Supraventricular tachycardia (SVT) or persistent
  • tachycardia during the course of treatment.

研究者

相似试验